12月20日，来自韩国的自然发酵化妆品品牌苏秘37°（SU:M37°）在北京三里屯CHAO酒店全新发布了扶愈抗皱高端发酵系列—— 鎏金溯茫Losec Summa系列产品 ...

of giving the wrong market authorization date to European patent offices in an attempt to extend its patent protection for the anti-ulcer blockbuster omeprazole (Losec). The company has also been ...

Swallow losec capsules the original patent protection acts as a very limited period. If you are taking this drug prescribed. Principe actif 20 mg once, daily. After drug was administered ...

Health Canada isalerting consumers who take Losec and Nexium, two prescription medications primarily used to treat acid-related stomach disorders, that it is investigating the drugs' links to ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

My daughter has reflux and was prescribed Losec from the age of 6 weeks - she is now four months old and still takes it. I was just wondering whether it was safe to take for an extended period of time ...

AstraZeneca has agreed to sell most global commercial rights to its gastro drug Losec (omeprazole) and associated brands to Germany’s Cheplapharm Arzneimittel in a deal worth up to $309 million.

Health Canada has completed a review of safety information for Losec (omeprazole) and Nexium (esomeprazole) and found no increased cardiovascular risks. Both prescription drugs are used to treat ...

I think that I might be pregnant, but I'm currently on Losec 20 for my ulcer. Can I use this medication and what side effect will it have for the baby and myself. Answer::You can take Losec in ...

DRUGS group AstraZeneca is facing a probe by the European Commission on suspicion that it misled authorities to protect its money-spinning anti-ulcer treatment Losec from competition. The European ...

However, sales of best-selling ulcer drug Losec slipped 6% to $1.4bn (£1bn) in the third quarter. Sold under the brand name of Prilosec in the US, sales of the drug represents 40% of group sales.

He is trying to navigate one of the biggest patent expiries in pharmaceutical history, which could see its blockbuster anti-ulcer drug Losec facing copycat competition for the first time.